Preclinical Evaluations of Therapies Combining the Vascular Targeting Agent Combretastatin A-4 Disodium Phosphate and Conventional Anticancer Therapies in the Treatment of Kaposi's Sarcoma

Author: Li Lingyun   Rojiani Amyn M.   Siemann Dietmar W.  

Publisher: Informa Healthcare

ISSN: 0284-186X

Source: Acta Oncologica, Vol.41, Iss.1, 2002-02, pp. : 91-97

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content